The cephalosporin group of antibiotics has gained widespread use in combating resistant infections. Because of the necessity for intravenous administration of cephalothin, and the intramuscular route for cephaloridine, the development of a new member of this series which is effective orally prompted study of its penetration into the eye. This is the first reported study of the passage of cephalexin into the aqueous humour.
Results
This study consisted of seventy specimens (35 each of serum and matched aqueous humour) from rabbits after oral cephalexin, and eight specimens (4 each of serum and matched aqueous humour) from healthy control rabbits. A total of 78 specimens was thus studied-39 serum and 39 aqueous humour. The Sarcina lutea disc-plate technique of bioassay was employed at the Lilly Laboratory, and the results were reported in jig./ml. No activity was found in any of the eight control specimens. The other data are summarized in the (Table, overleaf ) and shown graphically in (Fig. I, overleaf) . The history of the cephalosporins is of interest. In July, I945, Prof. Giuseppe Brotzu conducted a search for antibiotic-producing micro-organisms off the coast of Sardinia in the Mediterranean sea. A micro-organism known as Cephalosporium acremonium was found to produce an antibiotic substance in the broth where it was grown. Brotzu (I 948) reported his results, and subsequently forwarded the organism to Oxford, England. Abraham, Newton, Schenck, Hargie, Olson, Schuurmans, Fisher, and Fusari (I 955) reported the isolation of three different antibiotics from the culture media on which the cephalosporin was produced: a penicillin (cephalosporin N), a series of antibacterial steroids (cephalosporin P), and a new antibiotic (cephalosporin C). Chauvette, Flynn, Jackson, Lavagnino, Morin, Mueller, Pioch, Roeske, Ryan, Spencer, and van Heyningen (I962) began to attempt semi-synthetic improvement of the effectiveness and spectrum of cephalosporin C, and the series of semi-synthetic cephalosporins resulted. Cephalothin has been available commercially as Keflin for several years. Cephaloridine has more recently been released as Loridine. Cephaloglycin is now being studied in the United States; preliminary studies by Dr. Robert Sexton (personal communication) are said to have shown reasonable penetration of the aqueous humour by cephalothin, and it was therefore thought reasonable to study this aspect of cephalexin.
Review of the data presented reveals that in the rabbit after a single oral dose of cephalexin 50 mg./kg., there is a prompt rise in the serum level of the antibiotic, which is highest at one hour, when it averaged i6 ,ug./ml. The level fell during the second hour to approximately 6 ,ug./ml., and remained at about this level for the next 2 hours. After the 6th hour the serum levels fell sharply.
Similarly, cephalexin appeared promptly in the aqueous humour in this species, and maximum levels were found I to 2 hours after administration, with an average level of 2 Ftg./ml. This fell during the third hour, and was very low after the fourth hour. However, it is seen that cephalexin does enter the aqueous humour in the non-inflamed rabbit eye, and averages about I5-20 per cent. of the serum level. This is a relatively good passage of an antibiotic across the blood-aqueous barrier, and especially in an agent given by the oral route. No side-effects were observed in the rabbits studied.
It may be mentioned at this point that preliminary investigation of cephalexin in the owl monkey (Aotus trivirgatus) in this laboratory has shown an interesting species difference from the rabbit. In the owl monkey, there is little entry of cephalexin into the aqueous humour during the first hour, but it is seen after 2 hours and appears to be increasing between the third and fifth hours. This was seen although the serum levels had fallen notably between the fourth and fifth hours.
The results obtained in two patients given a single oral dose of cephalexin before ocular surgery might be mentioned. One patient was given o 5 g. cephalexin by mouth and simultaneous samples of serum and aqueous humour were obtained 2j hours later. The serum level was 8-20 ,tg./ml. and the aqueous humour level was o070 tig./ml. Another patient received a single i *o gram oral dose of cephalexin, and specimens obtained 31 hours later revealed a serum level of 6'20o 4g./ml. and an aqueous humour level of 0o78 pg./ml.
Thus, in two patients with white and quiet eyes, about I2 per cent. of the serum level was found in the aqueous humour.
Because of the reported efficacy of cephaloridine in the treatment of patients with early syphilis (Glicksman, Short, and Knox, I968) , cephalexin was given orally to an owl monkey with a histologically proven late syphiloderm and produced prompt healing of a lesion which had been present in a chronic state for over 8 months before therapy. It is thought that further investigation of cephalexin for use in ophthalmology is indicated.
Summary
Cephalexin is a new semi-synthetic cephalosporin derivative which possesses the advantage over cephalothin and cephaloridine of being effective when taken by mouth. It is rapidly absorbed and appears promptly in the aqueous humour of the non-inflamed rabbit eye. Aqueous humour levels were obtained averaging 15-20 per cent. of the serum levels. Cephalexin merits further investigation in ophthalmology. 
